Additionally, with the analysis of tumor immunity and chemoresistance, we were the first to demonstrate that LSM5 and LSM8 were tightly correlated with chemoresistance and immune infiltration, and thus might be potential biomarkers for predictions of survival in GC patients. The gene discussed is LSM8; the disease is gastric cancer.